The Path to Diagnosis: Labs and Genetics

Confirming a diagnosis of HO-1 deficiency requires a combination of specialized blood work and genetic testing. Because the condition is so rare, the typical patterns doctors look for in other blood disorders are often flipped or “missing,” which can lead to confusion during the initial diagnostic process.

The Cardinal Clue: Hemolysis Without Jaundice

The most important laboratory “clue” for HO-1 deficiency is a specific type of anemia called direct-antibody-negative hemolytic anemia ^[1][2].

Usually, when red blood cells break down (hemolysis), they release heme, which the body converts into bilirubin. This causes the skin and eyes to turn yellow (jaundice). In HO-1 deficiency, the “recycling plant” (the HO-1 enzyme) is broken ^[3]. As a result:

• Bilirubin is normal or abnormally low: This is highly unusual for someone with active hemolysis ^[2][4].
• Heme and Iron Build Up: Because they cannot be properly converted, raw heme and iron remain in the body and can eventually deposit into organs ^[5].

Blood Markers to Track During Flares

During acute hyperinflammatory flares, your child’s blood work may mimic other conditions like HLH (hemophagocytic lymphohistiocytosis) or MAS (macrophage activation syndrome) ^[1][6]. Key markers often include:

• Elevated Ferritin and Triglycerides: These are markers of intense systemic inflammation ^[6][1].
• Reduced Fibrinogen: Low levels of this clotting protein can indicate the body is under extreme inflammatory stress ^[6].
• Leukocytosis and Thrombocytosis: Unlike other inflammatory syndromes where blood counts often drop, HO-1 deficiency frequently causes a massive increase in white blood cells and platelets ^[1][6].

Definitive Genetic Testing

Molecular testing (such as targeted gene panels, exome sequencing, or genome sequencing) is needed to look at the HMOX1 gene ^[6][7].

• Biallelic Mutations: The report must show causative mutations (one on each copy of the gene). These can be the same mutation (homozygous) or two different ones (compound heterozygous) ^[1][6].
• Segregation Testing: Doctors will often test both parents to confirm that each parent carries one of the mutations. This “segregation” helps establish the condition was inherited in an autosomal recessive pattern ^[1][6].

Biopsies and Bone Marrow

Biopsies are not routinely required to confirm the diagnosis, and should only be performed for specific clinical indications. If a diagnosis is still uncertain, or organs need to be evaluated, doctors may perform a biopsy or bone marrow aspiration:

• Iron Deposits: Biopsies of the liver or kidneys may show significant iron buildup within the cells ^[6].
• Bone Marrow: During a flare, the marrow may show hemophagocytosis (where immune cells begin “eating” blood cells) ^[1]. However, it is important to know that a normal bone marrow result does not rule out the disease, as many confirmed patients have had normal marrow results between flares ^[6].

Completeness Checklist for Your Records

When reviewing reports with your medical team, ensure you have the following information:

1. Genetic Report: Confirms two mutations in the HMOX1 gene.
2. Parental Testing: Confirms both parents are carriers of the identified mutations.
3. Hemolysis Panel: Shows high LDH, low haptoglobin, and a negative Direct Antiglobulin Test (DAT/Coombs).
4. Bilirubin Levels: Documents that total and direct bilirubin are not elevated despite the anemia.
5. Inflammatory Baseline: Records “quiet” levels of ferritin, triglycerides, and fibrinogen for comparison during a future flare.